Skip to main content
logo
Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
2.440
+0.020 (0.83%)
At close: Oct 9, 2026, 4:00 PM EDT
2.480
+0.040 (1.64%)
After-hours: Oct 9, 2026, 7:36 PM EDT

Atossa Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
247611911067203
Market Cap Growth
-83.02%-35.83%7.71%64.77%-66.97%445.88%
Enterprise Value
-2244417-5063
Last Close Price
2.448.8514.1613.207.9324.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-181.67181.67181.67181.67181.67
PB Ratio
0.911.941.661.210.571.47
P/TBV Ratio
0.911.941.661.210.571.47
PEG Ratio
-2.422.422.422.422.42

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-0.97-1.05-0.99-0.97-0.94-0.99
Net Debt / EBITDA Ratio
0.671.112.582.824.016.65
Net Debt / FCF Ratio
0.731.393.384.225.348.28
Quick Ratio
4.795.0014.3116.9020.0543.97
Current Ratio
5.695.5314.9917.6121.2345.18
Return on Equity (ROE)
-89.23%-62.74%-31.39%-28.80%-21.05%-24.93%
Return on Assets (ROA)
-50.69%-37.43%-19.99%-17.84%-13.07%-13.93%
Return on Capital Employed (ROCE)
-146.30%-94.40%-38.60%-34.50%-23.50%-14.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-154.87%-45.62%-21.47%-27.29%-40.29%-10.17%
FCF Yield
-146.96%-39.08%-17.72%-19.00%-31.06%-8.13%
Buyback Yield / Dilution
-1.95%-2.63%0.18%0.43%-8.27%-934.13%
SEC Filings: 10-K · 10-Q